Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein-Reference-Cited by-同舟云学术

Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein

Published:2010-10-12 Issue:1 Volume:102 Page:25-35
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Masuko Takashi,Ohno Yoshiya,Masuko Kazue,Yagi Hideki,Uejima Shinya,Takechi Masayuki,Hashimoto Yoshiyuki

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01741.x/fullpdf

Reference80 articles.

1. Continuous cultures of fused cells secreting antibody of predefined specificity;Köhler;Nature,1975

2. Potent antibody therapeutics by design;Carter;Nat Rev Immunol,2006

3. Rituximab in the treatment of non-Hodgkin’s lymphoma;Hauptrock;Biologics,2008

4. Ofatumumab;Keating;Nat Rev Drug Discov,2010

5. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat Rev Cancer,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual‐targeting therapy against HER3/MET in human colorectal cancers;Cancer Medicine;2023-02-07

2. Analysis of Target Molecules towards Anti-cancer Therapeutic Antibodies;YAKUGAKU ZASSHI;2021-01-01

3. Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene;Cancer Science;2020-12-11

4. Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS ‐mutated human colorectal cancer cells;Cancer Medicine;2019-11-10

5. Anti‐tumor effects of mAb against l ‐type amino acid transporter 1 ( LAT 1) bound to human and monkey LAT 1 with dual avidity modes;Cancer Science;2019-01-04